Sure but the price would be better after validation. It would be even better than that after FDA approval. Remember, there are a lot of outstanding shares to spread revenues over so it's going to take lots of revenue to cause a significant value increase in mhtx pps.
Once again, MHTX does not intend to manufacture and sell MRX machines. It intends to license the technology and allow the licensee to manufacture and sell the machines. Therefore the license fee is going to have to be a whopper! Royalties will also play a role in ongoing revenue.
Mitch i don.t think anything will happen until it,s all validated in the lab. Md docs will be the guys who say it is a killer app and most large healthcare co,s are at MD the news will travel fast and I would expect a bidding war only if it overpowering results
News 
Market Data 
Discover 
AI
